Glenmark Life Sciences Ltd. IPO

It is a wholly-owned subsidiary of Glenmark Pharma and the leading manufacturer of selected APIs in chronic therapeutic areas.

RHP
View
DRHP
View
Open Date

2021-07-27

Close Date

2021-07-29

IPO Details

Check out the issue details for Glenmark Life Sciences Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 720

Price Band

₹ 695 - 720

Issue Size

1513.6 Cr.

Issue Type

Book Built

Open

2021-07-27

Close

2021-07-29

Listingprice

₹ 750

ListingGain

4.17%

Listing Date

2021-08-06

CMP

₹ 877.55

Current Return

21.88%

Company Financials

You can get the following financial statements of Glenmark Life Sciences Ltd. as of now.

Subscription Details

The valuation of Glenmark Life Sciences IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 720
Total Shares 12.25 Cr
Market Cap 8820 Cr
EPS  Rs 28.69 
PE Ratio 25x
Industry PE 37x

 

Glenmark Life Sciences IPO issue size is 1513.6 Cr. 

Issue Amount
Fresh Issue 1060 Cr
Offer For Sale 453.6 Cr

 

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,400
 Maximum 13 260 Rs 1,87,200

 

Glenmark Life Sciences IPO is subscribed 44.17 times till 29th July. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 36.97 Times
Non-Institutional Minimum 15% 122.54 Times
Retail Individual Minimum 35% 14.63 Times
Total 100% 44.17 Times

Allotment Details

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Glenmark Life Sciences IPO:

Schedule Date
Basis of Allotment 03 August 2021
Refunds 04 August 2021
Credit to Demat Account 05 August 2021
IPO Listing Date 06 August 2021

When the allotment is out, you can check it from the registrar's website. Find the Glenmark Life Sciences IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 886.42 1537.31 1885.17 2123.21 2161.22
Total Expenditure 639.25 1065.35 1294.09 1507.15 1518.93
Operating Profit 247.18 471.96 591.07 616.06 642.29
Other Income 0.99 11.99 0.81 14.7 28.96
Interest 0.61 33.52 87.55 27.96 0.55
Depreciation 19.26 29.37 33.39 37.88 42.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 228.3 421.07 470.94 564.93 628.61
Provision for Tax 32.71 107.97 119.36 146.2 161.65
Net Profit 195.59 313.1 351.58 418.72 466.96
Adjusted EPS (Rs.) 1.81 2.9 3.26 3.42 3.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 1.96 1.96 1.96 24.51 24.51
Total Reserves 86.17 399.73 750.79 2029.81 2113.7
Borrowings 0 0 0 0 0
Other N/C liabilities 6.86 16.45 22.89 32.7 59.53
Current liabilities 1380.41 1307.46 1444.93 746.8 1022.76
Total Liabilities 1475.4 1725.6 2220.57 2833.81 3220.49
Assets
Net Block 456.31 546.25 572.8 589.76 780.63
Capital WIP 80.33 10.73 14.1 91.69 49.35
Intangible WIP 0.07 0 0 5.27 12.26
Investments 0.08 0.08 0.08 0.08 0.08
Loans & Advances 7.92 8.44 11.06 19.63 9.49
Other N/C Assets 0 0 0 0 0
Current Assets 930.7 1160.11 1622.53 2127.39 2368.68
Total Assets 1475.4 1725.6 2220.57 2833.81 3220.49
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Other Income 6.61 2.84 1.85 5.37 1.69
Profit Before Tax 141.14 197.63 182 158.93 160.68
Tax 36.15 51.27 46.55 40.19 41.92
Profit After Tax 104.99 146.36 135.45 118.74 118.77
Adjusted EPS (Rs) 8.57 11.95 11.05 9.69 9.69

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 82.85 9.47
Sep 2023 82.85 9.47
Jun 2023 82.85 0
Mar 2023 82.85 0
Dec 2022 82.85 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 228.3 421.07 470.94 564.93 628.61
Adjustment -101.15 56.74 133.31 70.99 35.32
Changes in Assets & Liabilities -93.26 -190.26 -107.58 99.84 -196.96
Tax Paid -23.54 -92.54 -108.56 -138.17 -153.57
Operating Cash Flow 10.35 195.01 388.11 597.59 313.4
Investing Cash Flow -8.83 -50.52 -68.73 -122.23 -154.15
Financing Cash Flow 0.54 -136.55 -213.78 -78.8 -387.59
Net Cash Flow 2.05 7.94 105.6 396.56 -228.33
X